New Delhi: Indian pharmaceutical industry needs to be more confident of its abilities and invest in innovation, which will deliver the returns after a few years, industry leaders said on Monday.
Speaking at the Indian Foundation for Quality Management's Third Annual Symposium here, Sun Pharma Executive Chairman Dilip Shanghvi, Biocon Executive Chairperson Kiran Mazumdar-Shaw and Glenmark Pharmaceuticals Chairman and Managing Director Glenn Saldanha stressed the need for sustained investments in research and development (R&D), regulatory reforms and ecosystem building.
